Home
About Us
Company Profile
Management Team
Development History
Honors & Qualifications
Intellectual Property Rights
Technology Platform
Clinical Testing Services
Companion Diagnostic
Dynamic Monitoring
Clinical Study
Pharma Services
YuceNeo
Core Strengths
Central Lab
Biomarker Development and Validation
Development of Neoantigens and Vaccines
Development of Companion Diagnostic
Data Services
Scientific Research
Research Strengths
Research Results
Meta Ladder Institute of Precision Cancer Medicine
Patient Home
Patient Story
News & Information
Company News
Media Reports
Talent Strategy
Staff
Talent Development
Join Us
CH
News&Information
News & Information
Home
>
News & Information
>
Company News
Company News
Media Reports
media reports
Media Reports
2018-12-25
贝壳社：大咖支招，破解医疗IP转化与落地难题
MORE
2018-12-10
36氪首发 ｜ 用基因检测寻找肿瘤免疫潜在获益患者，「裕策生物」获数亿元B轮融资
MORE
2018-12-04
基因慧：专访裕策生物CEO高志博｜“抗癌天梯”搭建正当时
MORE
2018-10-10
丁香园：裕策生物 CEO 高志博专访：新生抗原，让肿瘤免疫更有效！
MORE
2018-08-23
《深圳直通车》：栏目摄制组探访裕策生物并作报道（内含企业宣传片）
MORE
2017-11-07
转化医学网： 裕策生物CEO高志博｜数百亿的免疫诊疗市场，已经揭开一角
MORE
First
Previous
1
2
3
4
Next
Last
About Us
Company Profile
Management Team
Development History
Honors & Qualifications
Intellectual Property Rights
Technology Platform
Clinical Testing Services
Companion Diagnostic
Dynamic Monitoring
Clinical Study
Pharma Services
YuceNeo
Core Strengths
Central Lab
Biomarker Development and Validation
Development of Neoantigens and Vaccines
Development of Companion Diagnostic
Data Services
Scientific Research
Research Strengths
Research Results
Meta Ladder Institute of Precision Cancer Medicine
Patient Home
Patient Story
News & Information
Company News
Media Reports
Talent Strategy
Staff
Career Development
Join Us
Copyright©2021
Shenzhen yucebio Technology Co., Ltd. all rights reserved
Yueicp no.16128839
Technical support: muxing planning
Top
